Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: combined results from two phase III, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2) - Blauvelt, A; Wollenberg, A; Pink, A; Peris, K; Armstrong, A; Spelman, L; Saeki, H; Lynde, C; Herranz, P; Barbarot, S; Simpson, E (BRITISH JOURNAL OF DERMATOLOGY, 2021)